KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $49,778,000 | +72.4% | 480,155 | -7.1% | 0.34% | +168.0% |
| Q3 2016 | $28,869,000 | -77.1% | 516,815 | -79.5% | 0.12% | -76.7% |
| Q2 2016 | $126,275,000 | +21.7% | 2,525,497 | +11.8% | 0.54% | +17.3% |
| Q1 2016 | $103,749,000 | -23.7% | 2,259,828 | +2.4% | 0.46% | -10.9% |
| Q4 2015 | $136,008,000 | -1.2% | 2,207,203 | -10.7% | 0.51% | -2.8% |
| Q3 2015 | $137,673,000 | +233.4% | 2,472,580 | +265.0% | 0.53% | +238.5% |
| Q2 2015 | $41,297,000 | +624.5% | 677,334 | +238.7% | 0.16% | +578.3% |
| Q3 2014 | $5,700,000 | – | 200,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |